Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4209-4231
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4209
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4209
Figure 4 Effects of Tzu-Chi cancer-antagonizing & life-protecting II decoction on protein expression of colonic ZO-1, NF-κB, Occludin, MUC-2, Claudin-1, and IκB-α in H22 hepatocellular carcinoma mice after chemotherapy.
A-G: Protein expression of ZO-1 (A), Occludin (B), IκB-α(C), MUC-2 (D), NF-κB (E), and Claudin-1 (F) and band map (G) of each protein by Western blot. Data with error bars are represented as the mean ± SD (n = 4). aP < 0.05 vs NS-Contr; bP < 0.01 vs NS-Contr; cP < 0.05 vs 5-fluorouracil (FU)-Contr; dP < 0.01 vs 5-FU-Contr; eP < 0.05 vs Yangzhengxiaoji capsules, one-way ANOVA. 5-FU: 5-fluorouracil; YZXJ: Yangzhengxiaoji capsules; TCCL-H: High-dose Tzu-Chi cancer-antagonizing & life-protecting II decoction; TCCL-M: Medium-dose Tzu-Chi cancer-antagonizing & life-protecting II decoction; TCCL-L: Low-dose Tzu-Chi cancer-antagonizing & life-protecting II decoction.
- Citation: Wang YN, Zhai XY, Wang Z, Gao CL, Mi SC, Tang WL, Fu XM, Li HB, Yue LF, Li PF, Xi SY. Jianpi-Huatan-Huoxue-Anshen formula ameliorates gastrointestinal inflammation and microecological imbalance in chemotherapy-treated mice transplanted with H22 hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(10): 4209-4231
- URL: https://www.wjgnet.com/1948-5204/full/v16/i10/4209.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i10.4209